Evidence map›Paper›PMID 16926565›Full record

ArticleAnnals of surgery2006

Parenteral nutrition impairs gut-associated lymphoid tissue and mucosal immunity by reducing lymphotoxin Beta receptor expression.

Woodae Kang, F Enrique Gomez, Jinggang Lan, Yoshifumi Sano, Chikara Ueno, Kenneth A Kudsk

Open access · greenAbstract readComparative Study
In one paragraph

Article in Annals of surgery, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Farnesoid X Receptor Agonist Tropifexor Improves Intestinal Defense Response and Epithelial Barrier Function in Neonatal Piglets Receiving Parenteral Nutrition.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  6. Review
  7. Review
  8. Article
  9. Gastrointestinal immune and microbiome changes during parenteral nutrition.American journal of physiology. Gastrointestinal and liver physiology · 2017
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Nutrition and gut immunity.The Surgical clinics of North America · 2011
    Review
  15. Article
  16. Article
  17. Whey protein potentiates the intestinotrophic action of glucagon-like peptide-2 in parenterally fed rats.American journal of physiology. Regulatory, integrative and comparative physiology · 2009
    Article
  18. Review
  19. Article
  20. Parenteral feeding depletes pulmonary lymphocyte populations.JPEN. Journal of parenteral and enteral nutrition
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Woodae KangDepartment of Surgery, University of Wisconsin-Madison College of Medicine and Public Health, Madison, WI, USA.
F Enrique Gomez
Jinggang Lan
Yoshifumi Sano
Chikara Ueno
Kenneth A Kudsk
University of Wisconsin–Madison · US

Funding

ENTERAL VS IV FEEDING--EFFECT ON MUCOSAL IMMUNITYR01GM053439 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI KUDSK, KENNETH A · 1998 to 2010
$2.9M
NIGMS NIH HHS R01 GM053439NIGMS NIH HHS R01 GM53439-06A1
6 · The paper itself

Abstract

objectiveTo determine the effects of parenteral nutrition (PN) on LTbetaR in gut-associated lymphoid tissue (GALT), particularly the intestine and Peyer's patches (PP). SUMMARY BACKGROUND DATA: Lack of enteral stimulation with PN impairs mucosal immunity and reduces IgA levels through depression of GALT cytokines (IL-4 and IL-10) and GALT specific adhesion molecules. We have shown that each is critical to intact mucosal immunity through effects on lymphocyte homing, IgA production, and resistance to antibacterial and antiviral immunity. IgA is the principal specific immunologic mucosal defense. LTbetaR stimulation controls production of IL-4, the adhesion molecule MAdCAM-1, and other key components of GALT, all of which are important in increasing IgA levels and maintaining mucosal defenses.

methodsExperiment 1: LTbetaR expression in intestine and PP was analyzed by Western blot after 5 days of chow, a complex enteral diet (CED), or PN. Diets were isocaloric and isonitrogenous except for chow. Experiment 2: After completing pilot experiments to determine the appropriate dose of the LTbetaR agonistic antibody, mice received chow, PN + 5 mug of anti-LTbetaR mAb (2 times/d, i.v.) or PN + isotype control antibody. PP lymphocytes and intestinal IgA levels were measured after 2 days.

resultsLack of enteral stimulation with PN significantly decreased LTbetaR expression in intestine and PP compared with chow and CED. LTbetaR stimulation with an agonistic anti-LTbetaR mAb significantly increased PP lymphocyte counts and intestinal IgA in PN fed-mice.

conclusionsLTbetaR expression is critical for GALT control mechanisms and intact mucosal immunity. PN reduces LTbetaR expression, PP lymphocytes, and intestinal IgA production. Exogenous LTbetaR stimulation reverses PN-induced depression of gut mucosal immunity.

Indexed as

Parenteral NutritionAnimalsAntibodies, Anti-IdiotypicBlotting, WesternEnzyme-Linked Immunosorbent AssayImmunity, MucosalImmunoglobulin AIntestinal MucosaIntestine, SmallLymphocyte CountLymphotoxin beta ReceptorMaleMiceMice, Inbred ICRPeyer's PatchesReceptors, Tumor Necrosis FactorAntibodies, Anti-IdiotypicImmunoglobulin ALtbr protein, mouseLymphotoxin beta ReceptorReceptors, Tumor Necrosis Factor

Identifiers

PMID16926565
PMCPMC1856545
OpenAlexW2089312158

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.